Severe pulmonary manifestation of leptospirosis

Netherlands Journal of Medicine

Volumn 70, Issue 5, 2012, Pages 215-221

  Helmerhorst, H J F ^a   van Tol, E N ^a   Tuinman, P R ^a   de Vries, P J ^a   Hartskeerl, R A ^b   Grobusch, M P ^a   Hovius, J W ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ROYAL TROPICAL INSTITUTE   (Netherlands)

Author keywords

Emerging infection; Epidemiology; Leptospirosis; Lung; Pulmonary manifestation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; AMOXICILLIN; AMPICILLIN; C REACTIVE PROTEIN; CREATININE; DOXYCYCLINE; ERYTHROMYCIN; METHYLPREDNISOLONE; PENICILLIN G;

ALBUMINURIA; ARTHRALGIA; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; COUGHING; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DRUG PULSE THERAPY; DYSPNEA; EYE REDNESS; FEVER; HEMATURIA; HEMOPTYSIS; HUMAN; HYPOTENSION; JAUNDICE; KIDNEY FAILURE; LEPTOSPIRA; LEPTOSPIROSIS; LEUKOCYTURIA; LIQUID FECES; LUNG HEMORRHAGE; MYALGIA; NECK PAIN; NEUTROPHIL COUNT; PATHOGENESIS; PROGNOSIS; REVIEW; SCLERA; SEROTYPE; SEVERE PULMONARY FORM OF LEPTOSPIROSIS; THAILAND; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; TRAVEL;

COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; HUMANS; LEPTOSPIROSIS; LUNG DISEASES; MALE; PREVALENCE; PROGNOSIS; PUBLIC HEALTH; YOUNG ADULT;

EID: 84866105745     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. WHO. Human leptospirosis: guidance for diagnosis, surveillance and control. 2003.
2. Hartskeerl RA, Collares-Pereira M, Ellis WA. Emergence, control and re-emerging leptospirosis: dynamics of infection in the changing world. Clin Microbiol Infect. 2011;17:494-501.
3. Socolovschi C, Angelakis E, Renvoise A, et al. Strikes, flooding, rats, and leptospirosis in Marseille, France. Int J Infect Dis. 2011;15:710-5.
4. Gouveia EL, Metcalfe J, de Carvalho AL, et al. Leptospirosis-associated severe pulmonary hemorrhagic syndrome, Salvador, Brazil. Emerg Infect Dis. 2008;14:505-8.
5. Lau C, Smythe L, Weinstein P. Leptospirosis: an emerging disease in travellers. Travel Med Infect Dis. 2010;8:33-9.
6. Vijayachari P, Sugunan AP, Shriram AN. Leptospirosis: an emerging global public health problem. J Biosci. 2008;33:557-69.
7. Hartskeerl RA. Leptospirosis: current status and future trends. Indian J Med Microbiol. 2006;24:309.
8. Tulsiani SM, Lau CL, Graham GC, et al. Emerging tropical diseases in Australia. Part 1. Leptospirosis. Ann Trop Med Parasitol. 2010;104:543-56.
9. Olszyna DP, Jaspars R, Speelman P, van Elzakker E, Korver H, Hartskeerl RA. [Leptospirosis in the Netherlands, 1991-1995]. Ned Tijdschr Geneeskd. 1998;142:1270-3.
10. Senior K. Leptospirosis and Weil's syndrome: cause for concern? Lancet Infect Dis. 2010;10:823-4.
11. Vieira ML, Gama-Simoes MJ, Collares-Pereira M. Human leptospirosis in Portugal: A retrospective study of eighteen years. Int J Infect Dis. 2006;10:378-86.
12. RIVM. Meer leptospirose in 2007. (http:/www.rivm.nl/Bibliotheek/Algemeen_Actueel/Uitgaven/Infectieziekten_Bulletin/Archief_jaargangen/Jaargang_19_2008/November_December_2008)
13. McBride AJ, Athanazio DA, Reis MG, Ko AI. Leptospirosis. Curr Opin Infect Dis. 2005;18:376-86.
14. Dupont H, Dupont-Perdrizet D, Perie JL, Zehner-Hansen S, Jarrige B, Daijardin JB. Leptospirosis: prognostic factors associated with mortality. Clin Infect Dis. 1997;25:720-4.
15. Panaphut T, Domrongkitchaiporn S, Thinkamrop B. Prognostic factors of death in leptospirosis: a prospective cohort study in Khon Kaen, Thailand. Int J Infect Dis. 2002;6:52-9.
16. Daher EF, Lima RS, Silva Junior GB, et al. Clinical presentation of leptospirosis: a retrospective study of 201 patients in a metropolitan city of Brazil. Braz J Infect Dis. 2010;14:3-10.
17. Herrmann-Storck C, Saint-Louis M, Foucand T, et al. Severe leptospirosis in hospitalized patients, Guadeloupe. Emerg Infect Dis. 2010;16:331-4.
18. Park SK, Lee SH, Rhee YK, et al. Leptospirosis in Chonbuk Province of Korea in 1987: a study of 93 patients. Am J Trop Med Hyg. 1989;41:345-51.
19. Trevejo RT, Rigau-Perez JG, Ashford DA, et al. Epidemic leptospirosis associated with pulmonary hemorrhage-Nicaragua, 1995. J Infect Dis. 1998;178:1457-63.
20. Goncalves AJ, de Carvalho JE, Guedes e Silva JB, Rozembaum R, Vieira AR. [Hemoptysis and the adult respiratory distress syndrome as the causes of death in leptospirosis. Changes in the clinical and anatomicopathologicalpatterns]. Rev Soc Bras Med Trop. 1992;25:261-70.
21. Evangelista KV, Coburn J. Leptospira as an emerging pathogen: a review of its biology, pathogenesis and host immune responses. Future Microbiol. 2010;5:1413-25.
22. Medeiros Fda R, Spichler A, Athanazio DA. Leptospirosis-associated disturbances of blood vessels, lungs and hemostasis. Acta Trop. 2010;115:155-62.
23. Pertuiset E, Fen Chong M, Duval G, Genin R. [Clinical aspects and prognostic factors of icterohemorrhagic leptospirosis in adults. Apropos of 249 cases in La Reunion]. Rev Med Interne. 1988;9:487-93.
24. Ashford DA, Kaiser RM, Spiegel RA, et al. Asymptomatic infection and risk factors for leptospirosis in Nicaragua. Am J Trop Med Hyg. 2000;63:249-54.
25. Doudier B, Garcia S, Quennee V, Jarno P, Brouqui P. Prognostic factors associated with severe leptospirosis. Clin Microbiol Infect. 2006;12:299-300.
26. Covic A, Goldsmith DJ, Gusbeth-Tatomir P, Seica A, Covic M. A retrospective 5-year study in Moldova of acute renal failure due to leptospirosis: 58 cases and a review of the literature. Nephrol Dial Transplant. 2003;18:1128-34.
27. Turhan V, Polat E, Murat Atasoyu E, Ozmen N, Kucukardali Y, Cavuslu S. Leptospirosis in Istanbul, Turkey: a wide spectrum in clinical course and complications. Scand J Infect Dis. 2006;38:845-52.
28. Abdulkader RC, Silva MV. The kidney in leptospirosis. Pediatr Nephrol. 2008;23:2111-20.
29. Segura ER, Ganoza CA, Campos K, et al. Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis. 2005;40:343-51.
30. Alston JM, Brown HC. The Epidemiology of Weil's Disease: (Section of Epidemiology and State Medicine). Proc R Soc Med. 1937;30:741-56.
31. Sitprija V, Losuwanrak K, Kanjanabuch T. Leptospiral nephropathy. Semin Nephrol. 2003;23:42-8.
32. Rabb H, Wang Z, Nemoto T, Hotchkiss J, Yokota N, Soleimani M. Acute renal failure leads to dysregulation of lung salt and water channels. Kidney Int. 2003;63:600-6.
33. Dolhnikoff M, Mauad T, Bethlem EP, Carvalho CR. Pathology and pathophysiology of pulmonary manifestations in leptospirosis. Braz J Infect Dis. 2007;11:142-8.
34. Courtin JP, di Francia M, Du Couedic I, et al. [Respiratory manifestations of leptospirosis. A retrospective study of 91 cases (1978-1984)]. Rev Pneumol Clin. 1998;54:382-92.
35. Paganin F, Bourdin A, Borgherini G, et al. [Pulmonary manifestations of leptospirosis]. Rev Mal Respir. 2009;26:971-9.
36. Marotto PC, Ko AI, Murta-Nascimento C, et al. Early identification of leptospirosis-associated pulmonary hemorrhage syndrome by use of a validated prediction model. J Infect. 2010;60:218-23.
37. Wagenaar JF, de Vries PJ, Hartskeerl RA. Leptospirosis with pulmonary hemorrhage, caused by a new strain of serovar Lai: Langkawi. J Travel Med. 2004;11:379-81.
38. Marchiori E, Lourenco S, Setubal S, Zanetti G, Gasparetto TD, Hochhegger B. Clinical and imaging manifestations of hemorrhagic pulmonary leptospirosis: a state-of-the-art review. Lung. 2011;189:1-9.
39. Tantitanawat S, Tanjatham S. Prognostic factors associated with severe leptospirosis. J Med Assoc Thai. 2003;86:925-31.
40. Spichler AS, Vilaca PJ, Athanazio DA, et al. Predictors of lethality in severe leptospirosis in urban Brazil. Am J Trop Med Hyg. 2008;79:911-4.
41. Ko AI, Galvao Reis M, Ribeiro Dourado CM, Johnson WD, Jr., Riley LW. Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet. 1999;354:820-5.
42. Ooteman MC, Vago AR, Koury MC. Evaluation of MAT, IgM ELISA and PCR methods for the diagnosis of human leptospirosis. J Microbiol Methods. 2006;65:247-57.
43. Panaphut T, Domrongkitchaiporn S, Vibhagool A, Thinkamrop B, Susaengrat W. Ceftriaxone compared with sodium penicillin G for treatment of severe leptospirosis. Clin Infect Dis. 2003;36:1507-13.
44. Suputtamongkol Y, Niwattayakul K, Suttinont C, et al. An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis. Clin Infect Dis. 2004;39:1417-24.
45. Azevedo AFC, Miranda-Filho DB, Henriques-Filho GT, Leite A, Ximenes RA. Randomized controlled trial of pulse methyl prednisolone x placebo in treatment of pulmonary involvement associated with severe leptospirosis. [ISRCTN74625030]. BMC Infect Dis. 2011;11:186.
46. Croda J, Neto AN, Brasil RA, Pagliari C, Nicodemo AC, Duarte MI. Leptospirosis pulmonary haemorrhage syndrome is associated with linear deposition of immunoglobulin and complement on the alveolar surface. Clin Microbiol Infect. 2010;16:593-9.
47. Shenoy VV, Nagar VS, Chowdhury AA, Bhalgat PS, Juvale NI. Pulmonary leptospirosis: an excellent response to bolus methylprednisolone. Postgrad Med J. 2006;82:602-6.
48. Tse KC, Yip PS, Hui KM, et al. Potential benefit of plasma exchange in treatment of severe icteric leptospirosis complicated by acute renal failure. Clin Diagn Lab Immunol. 2002;9:482-4.
49. Takafuji ET, Kirkpatrick JW, Miller RN, et al. An efficacy trial of doxycycline chemoprophylaxis against leptospirosis. N Engl J Med. 1984;310:497-500.
50. Sehgal SC, Sugunan AP, Murhekar MV, Sharma S, Vijayachari P. Randomized controlled trial of doxycycline prophylaxis against leptospirosis in an endemic area. Int J Antimicrob Agents. 2000;13:249-55.
51. Wang Z, Jin L, Wegrzyn A. Leptospirosis vaccines. Microb Cell Fact. 2007;6:39.